Targeting N-myristoyltransferases in cancer: when the end justifies the means
Pacylex CSO Dr. Luc Berthiaume recently published an overview of the recent Nature paper and the idea behind his research in Nature Cancer. You can find it here.
November 4, 2020
Pacylex: Targeting myristoylation to selectively kill cancer.